I'm considering all the data we already have to support a very quick and simple trial for topical brilacidin. I think it can be manufactured (in progress now) and get licensed. How much it brings us pales in comparison to prurisol and even more so for brilacidin UP and OM, all three of which still have more significant trials to get through. Bp's appetite for our pipeline is pretty strong imo, I do think we are very close to a deal for moving the brilacidin platform forward. This is going to be a fun ride. Thinking they're just waiting for that prurisol data to hit.

https://www.ipharminc.com/brilacidin-1/

https://academic.oup.com/femsre/article/41/3/323/3830264